Industrial Goods » Machinery | Galaxy Biomedical Investment Co. Ltd.

Galaxy Biomedical Investment Co. Ltd. A | Cash Flow

Fiscal year is January-December. All values CNY Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
12,371.70
22,998.20
102,585.00
16,422.50
14,620.40
736,342.70
Depreciation, Depletion & Amortization
46,837.70
47,182.30
58,248.70
44,182.50
46,356.90
47,856.60
Other Funds
55,218.00
54,206.30
1,122,184.40
24,191.80
15,484.70
456,482.10
Funds from Operations
75,723.00
65,419.40
71,482.70
93,652.40
47,128.90
201,831.20
Changes in Working Capital
8,115.50
13,994.10
166,790.80
6,669.10
112,166.10
170,692.30
Net Operating Cash Flow
67,607.40
51,425.30
95,308.10
100,321.50
65,037.20
372,523.50
Capital Expenditures
8,401.40
9,333.30
19,964.20
38,547.90
65,181.20
Sale of Fixed Assets & Businesses
15,536.90
79.30
16,297.90
20,095.40
730.50
Purchase/Sale of Investments
-
133,594.10
66,443.20
376,609.90
348,666.10
Net Investing Cash Flow
66,541.60
115,096.70
76,113.60
389,034.20
382,165.60
Issuance/Reduction of Debt, Net
101,600.00
100.00
596,961.90
144,000.00
340,000.00
Net Financing Cash Flow
156,818.00
54,106.30
525,222.50
119,808.20
324,515.30
Net Change in Cash
22,685.60
112,460.20
353,805.60
168,948.00
122,639.60
Free Cash Flow
59,206.00
42,092.00
115,272.40
61,773.60
130,218.40
Deferred Taxes & Investment Tax Credit
294.10
2,830.30
26,425.40
9,115.90
12,742.90
30,172.70
Net Assets from Acquisitions
-
1.90
166,044.00
-
-
Other Sources
59,927.90
-
32,142.10
10,937.20
37,009.40
Exchange Rate Effect
16.60
44.50
4.80
43.40
48.00
Other Uses
521.70
9,241.50
4,988.50
4,909.00
6,058.20

About Galaxy Biomedical Investment Co.

View Profile
Address
Galaxy Software Technology Park
Beihai Guangzi Zhuang 536000
China
Employees -
Website http://www.g-biomed.com
Updated 07/08/2019
Galaxy Biomedical Investment Co., Ltd. engages in the provision of investment in bio-pharmaceutical industry, transmission and distribution system industry, and electronic information industry. The company focuses on biotechnology and build its pharmaceutical and medical service industry structure; production and sale of transformer products; and manufacture of resistors, sensors, brake resistor box, radio frequency components, and potentiometers. The company was founded on June 20, 1993 and is headquartered in Beihai, China.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.